Hatakeyama K, Ohshima K, Nagashima T, Ohnami S, Ohnami S, Serizawa M, et al. Molecular profiling and sequential somatic mutation shift in hypermutator tumours harbouring POLE mutations. Sci Rep. 2018;8:8700 pubmed publisher
..Our strategy for estimation of the footprint of somatic mutations may provide new insight towards the understanding of mutation-driven tumourigenesis. ..
Hatakeyama K, Fukuda Y, Ohshima K, Terashima M, Yamaguchi K, Mochizuki T. Placenta-specific novel splice variants of Rho GDP dissociation inhibitor ? are highly expressed in cancerous cells. BMC Res Notes. 2012;5:666 pubmed publisher
..Expression of ARHGDIB variants 6a, 6b, and 6c appears to be restricted to cancer cells and normal placental tissue, suggesting that these variants possess cancer-specific functions and, as such, are potential cancer-related biomarkers. ..